Hope to erase the blurry vision of age


Ever held a newspaper at arm’s length to read the fine print?

Then you might benefit from the development of eye drops that literally could change the way some 100 million Americans see.

The drops were developed by Encore Vision with support from the Tech Fort Worth-UNT Health Science Center Accelerator Lab. They treat presbyopia, a condition that causes blurry near vision as people age.

"Right now there is no medical treatment for presbyopia, just glasses or surgery," said Bill Burns, Encore Vision President and CEO. "And presbyopia is a condition that virtually everyone over 45 experiences."

The eye drops work by reducing stiffness in the eye lens that occurs with aging. By restoring flexibility, the drops allow the lens to thicken in the center, making it easier to focus on nearby objects.

"The drops are made from natural agents found in the body," Burns said. "So the body doesn’t have to figure out how to metabolize them, a key safety feature."

Burns turned to the TechFW-UNTHSC Accelerator Lab for help in the early stages of development. Having access to lab space, equipment and other facilities was a real benefit, he said.

"The resources available at the Accelerator Lab have proven to be an enormous asset to a start-up company like ours," he said. "The easy access to the vast treasure trove of publications, data and research was truly essential."

"Encore Vision was the right kind of company for the partnership represented by the TechFW-UNTHSC Accelerator Lab," said Joe Allred, Associate Vice President for Research and Innovation.
 
The way Encore Vision has progressed is a good example of how TechFW and UNTHSC provide much more than just space for Accelerator Lab clients, said Darlene Boudreaux, Executive Director of Tech Fort Worth.

"TechFW staff helped Bill put together a business model that would work, coached him on presenting a business that would interest the right investors, then put him in front of our Cowtown Angel Network," she said.

Encore Vision expects to move to human clinical trials by early next year. The therapeutic dosage has not been established, but Burns said the clinical program will help them determine dosing frequency and duration of treatment.

"Our intent is by using these drops daily, people can eliminate entirely or at least reduce their dependency on readers," he said.

Recent News

Heads Up
  • Our People
|May 3, 2024

Pharmaceutical sciences faculty awarded patents

Two members of The University of North Texas Health Science Center at Fort Worth’s College of Pharmacy faculty have made significant strides in their respective fields. Dr. Kyle Emmitte, an expert in medicinal chemistry, and Dr. Jin Liu, specializing in computational drug design, joined forces on ...
Hsc Pt In Dc
  • Our People
|May 2, 2024

HSC students highlight importance of physical therapy in D.C.

Prior to coming to The University of North Texas Health Science Center at Fort Worth, Do Kyung Yun advocated alongside community members in his Los Angeles neighborhood. As a community organizer, Yun, a second-year physical therapy student who is known to friends as “DK,” used to frequent meetin...
58ea6a4e 2ebd 4474 Aa12 D704cc7e3475
  • Our People
|May 2, 2024

Dr. Tracy Hicks reelected board member-at-large of the Fellows of the American Association of Nurse Practitioners

Tracy Hicks, DNP, MBA, APRN, FNP-BC, PMHNP-BC, CARN-AP, FIAAN, FAANP, associate professor at The University of North Texas Health Science Center at Fort Worth’s College of Nursing, was recently re-elected as board member-at-large of the Fellows of the American Association of Nurse Practitioners. ...
Justin New
  • Our People
|May 2, 2024

SaferCare Texas appoints new director

Justin Burton has been appointed as the new director of SaferCare Texas, The University of North Texas Health Science Center at Fort Worth's department dedicated to enhancing patient safety initiatives across the state. Burton is a registered nurse with more than 20 years of experience....